Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA600428
Max Phase: Preclinical
Molecular Formula: C25H25N3O5
Molecular Weight: 447.49
Molecule Type: Small molecule
Associated Items:
ID: ALA600428
Max Phase: Preclinical
Molecular Formula: C25H25N3O5
Molecular Weight: 447.49
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Cc1ccc(Oc2cccc(CN3CCN(C(=O)Oc4ccc([N+](=O)[O-])cc4)CC3)c2)cc1
Standard InChI: InChI=1S/C25H25N3O5/c1-19-5-9-22(10-6-19)32-24-4-2-3-20(17-24)18-26-13-15-27(16-14-26)25(29)33-23-11-7-21(8-12-23)28(30)31/h2-12,17H,13-16,18H2,1H3
Standard InChI Key: PNDGXRXVUAOTAB-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 447.49 | Molecular Weight (Monoisotopic): 447.1794 | AlogP: 5.01 | #Rotatable Bonds: 6 |
Polar Surface Area: 85.15 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 0 |
#RO5 Violations: 1 | HBA (Lipinski): 8 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: | CX Basic pKa: 6.28 | CX LogP: 5.22 | CX LogD: 5.19 |
Aromatic Rings: 3 | Heavy Atoms: 33 | QED Weighted: 0.39 | Np Likeness Score: -1.40 |
1. Long JZ, Jin X, Adibekian A, Li W, Cravatt BF.. (2010) Characterization of tunable piperidine and piperazine carbamates as inhibitors of endocannabinoid hydrolases., 53 (4): [PMID:20099888] [10.1021/jm9016976] |
Source(1):